National Cancer institute - Cancer Science

What is the National Cancer Institute?

The National Cancer Institute (NCI) is a part of the National Institutes of Health (NIH), which is itself a component of the U.S. Department of Health and Human Services. Established by Congress in 1937, the NCI leads the nation's efforts in cancer research, providing funding and support for a variety of scientific endeavors aimed at understanding, preventing, diagnosing, and treating cancer.

What are the primary goals of the NCI?

The NCI aims to reduce the burden of cancer through rigorous scientific research. Its primary goals include:

Understanding cancer biology
Improving cancer prevention and early detection
Developing and optimizing cancer treatments
Training the next generation of cancer researchers
Disseminating information to patients, healthcare providers, and the public

How does the NCI support cancer research?

The NCI supports cancer research through a variety of mechanisms, including:

Funding grants for basic, translational, and clinical research
Providing resources such as biorepositories and data sets
Conducting intramural research at NCI laboratories
Collaborating with other institutions and industry partners

What are some key programs and initiatives of the NCI?

The NCI oversees numerous programs and initiatives aimed at advancing cancer research, including:

The Cancer Genome Atlas (TCGA)
The Cancer Moonshot Initiative
The NCI Community Oncology Research Program (NCORP)
The Pediatric MATCH Trial

How does the NCI disseminate cancer information?

The NCI plays a critical role in disseminating accurate and up-to-date cancer information via:

Its official website, which provides resources for patients, healthcare providers, and researchers
The Cancer Information Service (CIS), offering personalized responses to cancer-related questions
Publishing research findings in scientific journals
Hosting conferences and workshops

How does the NCI support cancer prevention and early detection?

The NCI funds and conducts research aimed at identifying risk factors and developing strategies for cancer prevention and early detection. This includes:

Studies on the impact of lifestyle factors such as diet, physical activity, and tobacco use
Research on genetic predispositions to cancer
Development and validation of screening tests and biomarkers

How can individuals and organizations get involved with the NCI?

There are numerous ways for individuals and organizations to engage with the NCI, including:

Applying for research grants and funding
Participating in clinical trials
Joining NCI-sponsored networks and consortia
Volunteering for patient advocacy and outreach programs

Relevant Publications

A dynamic microRNA profile that tracks a chemotherapy resistance phenotype in osteosarcoma. Implications for novel therapeutics.

Issue Release: 2024

Dietary Quality and Diet-Related Factors Among U.S. Emerging Adults (18-23y) Are a Cause for Concern, NHANES 2015-2018.

Issue Release: 2024

High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China.

Issue Release: 2024

Deep learning models for predicting the survival of patients with hepatocellular carcinoma based on a surveillance, epidemiology, and end results (SEER) database analysis.

Issue Release: 2024

A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors.

Issue Release: 2024

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study.

Issue Release: 2024

Mexican Multicenter Experience of Metastatic Spinal Disease.

Issue Release: 2024

Outcomes of Head and Neck Neurogenic Tumors.

Issue Release: 2024

Genetic ancestry is related to potential sources of breast cancer health disparities among Colombian women.

Issue Release: 2024

Scalable Telehealth Cancer Care: integrated healthy lifestyle program to live well after cancer treatment.

Issue Release: 2024

Ethnic differences in the patterns, sources, and reasons for cannabis use among cancer patients at an NCI-Designated Cancer Center.

Issue Release: 2024

Cannabis and opioid perceptions, co-use, and substitution among patients across 4 NCI-Designated Cancer Centers.

Issue Release: 2024

Concurrent substance use among cancer patients with and without a history of cannabis use since cancer diagnosis at an NCI-Designated Cancer Center in Florida.

Issue Release: 2024

Communicating effectively to patients about a cancer referral.

Issue Release: 2024

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma.

Issue Release: 2024

Kazimierz Funk: Polish vitamins\' discoverer.

Issue Release: 2024

Green Propolis: A Review of Pharmaceutical Patents with Potential Therapeutic Applications.

Issue Release: 2024

The Immunopeptidomics Ontology (ImPO).

Issue Release: 2024

Natural compound Alternol exerts a broad anti-cancer spectrum and a superior therapeutic safety index .

Issue Release: 2024

Evaluating the safety of high-intensity focused ultrasound treatment for rectal endometriosis: results from a French prospective multicentre study including 60 patients.

Issue Release: 2024

What Services Are Available for Cancer Patients?

What Are the Challenges in Data Analysis?

How Does Research and Innovation Impact Cancer Treatment?

Why is Data Interoperability Important in Cancer Care?

What are advanced imaging techniques used in cancer diagnosis?

What Therapeutic Strategies Target Control Proteins?

What is Cancer Progression?

Are There Any Limitations or Exclusions?

How Does Multiplexing Enhance Diagnostic Accuracy?

What are the Limitations of Biochemical Tests in Cancer?

Partnered Content Networks

Relevant Topics